SPL Set ID: 82948cdb-73af-4f3f-bd03-628ed0fdbfba
1 drug(s) with this SPL Set ID
Ranolazine extended-release tablets are available as a film-coated, non-scored, extended-release tablet for oral administration. Ranolazine is a racemic mixture, chemically described as (±)N-(2,6-dimethylphenyl)-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperzin-1-yl]acetamide. It has an empirical formula of C 24 H 33 N 3 O 4 , a molecular weight of 427.55 g/mole, and the following structural formula: Ranolazine is a white to off-white powder. Ranolazine is soluble in dichloromethane. Ranolazine extended-release tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: hypromellose, magnesium stearate, methacrylic acid and ethyl acrylate copolymer (contains sodium lauryl sulfate and polysorbate 80), microcrystalline cellulose, and sodium hydroxide. In addition, the film coating contains the following inactive ingredients: FD&C blue #1, FD&C blue #2, polyethylene glycol, polyvinyl alcohol, talc and titanium dioxide. ranolazine-structure